BusinessBioSig Technologies to Present at 8th Annual Biotech ShowcaseBy Nasdaq OMXJan 6, 2016, 1:00 PM UTC
Insights & ViewsGene editing in embryos is fraught with scientific and ethical issuesBy The ConversationDec 2, 2015, 1:30 AM UTC
BusinessAgile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey’s Technology Business Tax Certificate Transfer ProgramBy Nasdaq OMXDec 1, 2015, 12:45 PM UTC
